FindTrial
Sign In

Study on dialysis adequacy through exhaled gas testing

Non-invasive Assessment of Hemodialysis Efficacy Based on Dynamic Monitoring of Exhaled Volatile Organic Compounds

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111763
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-11-11
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with stage 5 chronic kidney disease (uremia) undergoing maintenance hemodialysis

Interventions

Uremic Hemodialysis Group:None
Non-Hemodialysis Control Group:None

Sponsors

Shanghai Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for the uremia hemodialysis patient group:(1) Age range:18-85 years old,(2)Diagnosed with CKD stage5(uremia),undergoing maintenance hemodialysis for =3 months,(3)Sign the informed consent. 2.Inclusion criteria for the non-hemodialysis control group:Age range: 18-85 years old.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria for the uremia hemodialysis patient group:Active infection, tumor, or severe liver dysfunction. 2.Exclusion criteria for non-hemodialysis control group:History of significant chronic diseases or acute illnesses.

Design outcomes

Primary

MeasureTime frame
Positive detection rate/relative abundance changes of exhaled characteristic VOCs.;—

Secondary

MeasureTime frame
Pre- and post-intervention changes in blood biochemical and immunological indicators.;—

Countries

China

Contacts

Public ContactTao Xiaoyang

Shanghai Second People's Hospital

18918857376@189.cn+86 21 63024401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026